Professional Documents
Culture Documents
Takeover Guide
Contact
Dr. Judit Budai
Szecskay Attorneys at Law
judit.budai@szecskay.com
Contents
Page
INTRODUCTION
CONSIDERATION
OFFER TIMETABLE
10
11
INTRODUCTION
Hungarian capital markets have undergone significant changes over the last two decades
and the legal framework regulating takeover bids reflect the evolving nature of local
markets and participants. Investors must view the law relating to takeover bids in light of
the recent transplant of the EC Directive on Takeover Bids into the Hungarian legal
framework. The following pages will outline the basic principles and legal provisions
regulating takeover bids in an attempt to familiarise the reader with the nature of such an
undertaking in the Hungarian market. Those preparing to participate in takeover bids are
advised to solicit professional advice.
Equally important provisions are found in the Company Act (Act IV of 2006 on Business
Associations) (the CA) regarding the establishment and operation of non public and
public companies and the legal mergers of companies registered in Hungary, as well as
in the Competition Act (Act LVII of 1996 on the Prohibition of Unfair and Restrictive
Market Practices) (the Competition Act), which contains certain merger control related
provisions. The Competition Office is the regulatory body charged with enforcing the
Competition Act, ensuring that Hungarian markets are competitive and comply with EC
regulations. Sections 199 205 of the CMA contain regulations on insider trading laws.
Information outside the public domain about, among other things, a public offer, which
may have a significant influence on a public company's value or share price, is inside
information under the CMA. The trading of a target's shares by a person who possesses
inside information may amount to insider trading, which has administrative and criminal
penalties under the Criminal Code (section 299/A, Criminal Code (Act IV of 1978).
Listing rules of the Budapest Stock Exchange (Listing rules) also contain relevant
regulations. The Budapest Stock Exchange is supervised by the FSA. The Listing Rules
are approved by the FSA, and listed companies must comply with them.
page | 1
shares acquired for the sole purpose of clearing and settling within usual a short
settlement cycle;
page | 2
acquisition of direct or indirect voting rights in the issuer) of any such person or entity
which knows, or ought to have known under normal and reasonable circumstances, that
the information possessed is inside information (i.e. not yet published) shall be deemed
insider trading. Irrespective, however, of whether the trading is insider or not, each and
every transaction of an insider entity holding more than 10% of the shares granting voting
rights or the equity and issued by a public company, must be reported to the FSA,
regardless of whether the transaction is carried out by the insider itself or via any agent.
Shareholders of limited liability companies and private companies limited by shares must
report a 75% interest to the Court of Registration. The Court of Registration can order the
target's acquirers or management to comply with the reporting duty, or fine them for a
failure to do so.
25% of the voting rights, if there are no other shareholders (excluding the bidder
or bidder group) holding, either directly or indirectly, more than 10% of the voting
rights.
If a mandatory bid contrary to the CMA, is not made, the FSA declares such noncompliance and any shareholding exceeding 33% (or 25%) must be sold within 60 days
of the FSA's declaration. The FSA can also impose a fine from HUF500,000 (about
US$3,100) to HUF100 million (about US$625,000).
The takeover bid must be made in advance of the intended acquisition. However, if a
person's shareholding reaches and exceeds 33% (or 25% if no other shareholder holds
more than 10%) of the target's voting shares in any of the following ways, it must be
notified to the FSA within two days, and the acquisition triggers a mandatory public offer
subsequently within 15 days of notification:
A voluntary offer may be made for less than all of the shares of the target, therefore, it is
often made for the remaining voting shares if the bidder has exceeded the thresholds for,
and made, a mandatory offer, but has not yet acquired 90% of the voting rights, and
wishes to squeeze out minority shareholders. In case of a voluntary offer a counter-offer
may not be made and a voluntary offer may not be made once a mandatory offer is
announced until its completion.
page | 3
provide information on the target, citing the duty not to disclose confidential information
on the corporation and not to serve insider information to third parties.
The CMA permits prior to the announcement of the draft public takeover bid, the board of
directors of the target to, upon request by the offerer, convey any information to the
offerer (or consultants) on the operation of the target, provided that the offerer must treat
such information confidentially in line with rules regarding the confidential treatment of
business secrets and securities secrets, as well as the prohibition on insider trading.
There is a general requirement of equal treatment of potential bidders, if other bidders
also wish to seek pre-announcement due diligence information, for example for the
purposes of making a counter-offer, even if the management of the target may not find
them equally friendly.
Another issue to be considered by any potential bidder is that if pre-announcement due
diligence is made and ultimately the published takeover bid is not made (for example, as
a result of market leaks, sudden volatility of prices and large volume trades which within a
relatively short period of time cause a significant mandatory bid price increase) all
potential subsequent transactions of such potential bidder are exposed to being deemed
insider trading.
This means that, although in Hungary the legislation and the FSA supports preannouncement due diligence, potential bidders must carefully consider whether they may
provoke a potential sudden price increase on such a relatively closed market.
It should be noted, however, that information in the public domain includes a wide variety
of items. Information in the public domain includes:
Regular and special reports, which must be published by public companies (under
the CMA) and listed companies (under the Listing Rules), to disclose essential details
about their financial position and the general development of their business. Regular
disclosure is made by submitting yearly and half-yearly (or quarterly for listed
category A companies) reports, and annual accounts. Disclosure requirements of the
CMA are harmonised with the Prospectus Directive and the Transparency Directive;
Court of Registration;
details from the corporate register, including details of directors, share capital and
direct and indirect shareholders holding more than 75% of the share capital;
page | 4
The bidder must keep undisclosed information about the company's operations
confidential, regardless of the announcement or closing of the public offer, and cannot use
it unlawfully (for example, by passing it on to third parties or using it for insider trading).
announce the draft bid to the FSA and file the offer document with it, to be
approved;
publish the announcement and the offer document in a national daily newspaper,
or the website of the target and the broker, or the website of the BSE, if the target
company is a listed company, or the website of the FSA or in its Official Gazette.
The announcement must state that the FSA's approval of the offer document is
pending and that the bidder has applied for competition clearance, if applicable.
The bidder must publish the FSA's decision, the offer document and the first and last day
of the offer period in the same manner the draft offer was published, immediately after it
has received the FSA's approval (or the deadline for the FSA's response). If the same
announcement is made in the above-mentioned different publications and at different
times, all deadlines commence as of the date of the latest publication. The bidder does
not have to send copies of the offer document to the target's shareholders.
The public takeover offer must include the following elements on the basis of data
required pursuant to the CMA:
The description of the offer must specify:
page | 5
the interest (direct or indirect) already held in the target by the bidder and any
close relative of the bidder, if the bidder is a natural person, and any other
persons acting in concert with the bidder;
its amount;
its composition (for example, the ratio of cash and securities, and a
description of any securities offered);
the designated place and method of accepting the offer (the declaration of
acceptance), and the conditions in which a proxy or an intermediary can be
involved;
the corporate name and address of the participating investment service provider;
the place where the bidder's future plans for the target (operating plan) and a
report of the bidder's business operations (bidder's business report) are open for
inspection;
if the bid is submitted jointly, the amount of shares to be sold to each bidder;
if applicable, a condition reserving the right to withdraw the offer if the interest
acquired as a result of the acceptance declarations is representing less than 50%
of all voting rights;
details about the compensation for potential loss of rights by voting preferential
shareholders as a result of implementing certain "break-through rights";
governing law and forum in the sale and purchase agreement to be concluded by
the offerer and the shareholders accepting the offer; and
The bidder and the investment service provider must attach the following to the offer
document for the FSA's approval:
if the bid is aimed at obtaining more than 90% control, the bidder's declaration of
its intention regarding the exercise of a call option for the remaining
shareholdings in the target;
page | 6
if the acquisition takes place by persons acting in concert and there is only one
bidder, the consortium agreement appointing the bidder; and
CONSIDERATION
Cash remains the most common form of consideration in takeover bids. With respect to
listed securities, the relevant regulatory requirements stipulate that consideration must be
at least the higher of:
the average stock market price weighted on the basis of the trading volume for
the 180 or 360-day period before the public offer is submitted to the FSA for
approval (the latter applies if within 180 days there were less than 36 trades). If
the target's shares are traded on several exchanges, the weighted average must
be calculated for each exchange individually and the highest must be taken into
account. The Hungarian Forint equivalent of trades at foreign exchanges is
calculated using the official Central Bank rates applicable on the trading dates; or
the equity per share price calculated using the target's latest audited and, if
applicable, consolidated annual financial statements; or
the highest price paid for target shares (or votes in the target) by the bidder and
affiliated persons within the 180-day period before the public offer is submitted to
the FSA for approval; or
the aggregate of the call price and fee of a call or repurchase option.
page | 7
For non-listed securities, the consideration in a public offer must be at least the higher of:
the market price weighted on the basis of the trading volume for the 180-day
period before the public offer is submitted to the FSA for approval;
the highest price paid for target shares (or votes in the target) by the bidder and
affiliated persons within the 180-day period before the public offer is submitted to
the FSA for approval;
the equity per share price calculated using the target's latest audited and, if
applicable, consolidated annual financial statements, or if audited figures are not
available, the latest published semi-annual or annual report; or
the aggregate of the call price and fee of a call or repurchase option.
Offering a price range in the offer is not possible, but it is possible to increase the offer
price during the acceptance period, if duly announced.
the target's board can seek a white knight (that is, an alternative bidder which the
target's board recommends) to make a competing bid;
the target's board can implement decisions of the general meeting made before
the announcement (or being informed of the intent to bid), provided that the
decisions relate to the target's normal course of business.
In addition, the bid is not deemed frustrated if the target's board acts according to the
resolutions adopted by its general meeting (called under the Company Act) after either:
page | 8
Act 2007 of CXVI, on the amendment of certain acts relating to public supply
undertakings of significant importance, effective as of October 24, 2007 (the so-called
LEX MOL, which is currently being revised by the European Commission in the course of
an infringement procedure) introduced protective measures. Such measures include the
requirement that, when making a public offer for the shares of a strategic public company
of significant importance from the perspective of energy and water supply, the offerer
must have an operating plan, which is a mandatory attachment of the bid approved by its
general meeting. More generally LEX MOL modified the CMA so that the target's board
is not prevented from frustrating the bid, unless explicitly regulated by the by-laws of the
public company.
The by-laws of public companies can also contain poison pills against hostile bids
(Company Act). For example, restrictions can be imposed on the voting rights that a
shareholder can exercise (maximum level of voting rights) or the general meeting can be
allowed to pass resolutions to frustrate a bid (such as introducing a capital increase).
Since almost all major stock exchange companies contain poison pills in their by-laws,
hostile bids are not common. LEX MOL also deleted section 299 (2) Company Act, which
regulated that the restriction of voting rights to a maximum level by the by-laws
automatically became ineffective when as a result of a successful public takeover bid, the
offerer acquired 75% of all shares granting voting rights.
However, breakthrough rights, which are allowed under Directive 2004/25/EC on takeover
bids (Takeover Directive), can be incorporated into the target's by-laws (sections 76/A
and 76/B, CMA). For example, provisions can be included to prevent the following
applying during the offer period:
Other provisions can also be included in the target's by-laws, for example, so that if the
bidder has acquired 75% of all shares granting voting rights during the takeover
procedure and convenes the general meeting to propose the amendment of the by-laws,
or appoint or remove a director or supervisory board member:
OFFER TIMETABLE
The FSA has 15 days to approve the offer, provided that if additional documents are
requested, or if the FSA requires the revision of the draft bid, the bidder has five days to
submit and the FSA has a further five days to approve.
Immediately upon receipt of approval by the FSA (or by the expiration of the deadline for
the FSA's response, which is not precedented, as the FSA always responds on the
submission of a draft bid or suspends the response time with good reasons), the bidder
must publish the FSA's decision, and the final offer document, by indicating the first and
last day of the acceptance period, similarly as the draft offer was published. The bidder
does not have to send copies of the offer document to the target's shareholders.
The starting date of the acceptance period must be within two-five days of the publication.
The duration of the acceptance period must be at least 30 days and no more than 65
days, including any potential extension, as the FSA may approve the extension of the
acceptance period once with a maximum of 15 days.
page | 9
The contents of the target's statutes are determinative of its response to a bid and
response strategies are discussed below. However, competing bids may be submitted if
the competing offer price exceeds the original bid by at least 5% (in Hungarian Forint). A
competing bid must be made at least 15 days before the acceptance period ends and it
must be similarly sent to the FSA and the Board of the target and announced as the
original offer. If a new competing bid is made which only differs from the previous
competing bid in terms of the consideration offered, the FSA decides whether to approve
it within three days of the new competing bid being filed. To avoid running through the
acceptance period of the original offer, the FSA would most probably suspend the original
acceptance period to assess the counter offer. The target's board can support a
competing bid. As a result of an approved counter offer the original offer and all
acceptance declarations become ineffective. There is no limitation on the number of
counter-offers that may be made.
The bidder must notify the FSA and publish the outcome of the public offer within two
days after the end of the acceptance period.
acquires at least 90% of all voting interest in the target within three months of the
successful completion of the bid;
provides evidence to the FSA that it has sufficient funds to exercise the squeeze
out.
The notification and publication of the intention of the bidder to exercise the call option
must specify the:
The bidder must also deposit the consideration at a bank registered in any EU member
state.
page | 10
If as a result of a successful takeover bid the bidder acquired 90% voting interest, the
minority shareholders, within 90 days of announcement by the bidder of acquiring 90%
shareholding, may exercise a put option at a price which is the higher of the original offer
price or the equity per share price based on the latest published audited annual balance
sheet of the target.
De-listing can take place at the target's request or automatically. According to the Listing
Rules of the BSE, the target can file an application for de-listing with the BSE if a public
offer or stock exchange offer for all its listed shares has been made.
If a bidder acquires more than 90% of the voting rights in a listed target and exercises its
squeeze-out right as outlined above, the listed target is automatically de-listed.
Second Test
Whether the combined net turnover in Hungary, during the previous financial year of the
following exceeds, HUF500 million (about US$2.2 million):
The Competition Office must receive notification if the above thresholds are met. The
substantive test applied by the Competition Office is whether the merger creates or
strengthens a dominant position, which would impede the formation, development or
continuation of effective competition in the relevant market.
The Competition Office must issue a decision to clear the transaction, prohibit it or clear it
subject to conditions within 45 days after notification for simple matters, and 120 days for
complex matters. If necessary, the Competition Office can extend these deadlines by 60
days. As clearance is required for a merger to be valid, it is not advisable to implement a
transaction before this is obtained. If there is a serious problem, the transaction can be
page | 11
delayed by the period of time needed for clearance, depending on whether the bidder has
notified the Competition Office in a timely manner.
Further governmental approvals may be necessary to acquire shares in certain
companies, such as banks, insurance companies and various companies belonging to
the energy industry. However, the CMA does not specify the effect of obtaining these
approvals on the public offer timetable. Nevertheless, it should be noted, that without
some of these approvals, the acquisition may be invalid and the time taken to obtain them
(if necessary) must therefore be considered as well as that for receiving merger control
clearance.
page | 12